FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000856937> ?p ?o ?g. }

• W2000856937 endingPage "161" @default.
• W2000856937 startingPage "153" @default.
• W2000856937 abstract "A mechanistic approach to advanced cancer pain management is proposed, based on the clinically perceived anatomical and pathophysiological mechanisms of pain generation. It is an extension of the World Health Organisation (WHO) analgesic ladder in which severity of pain is the principal determinant of analgesic choice. The mechanistic categories are: superficial somatic, deep somatic, visceral and neurogenic (mixed or pure i.e., nociceptive component present or absent). Allocation of pain to the different categories is based on clinical history, physical findings and investigations to establish the site and extent of active primary or metastatic tumour deposits, and evidence of previous response to medication. Drug choice sequence is determined by the dominant pain mechanism judged to be present and not the severity of the pain. In order to describe this approach, mechanisms of pain, disease distribution and drug treatment have been analysed in the first 20 consecutive patients who consented to enter a longitudinal pain description and evaluation study on admission to an inpatient hospice unit. Despite a high exclusion rate from research standard monitoring due to severity of illness and related factors, the majority of eligible patients approached to enter the study did so, and the pain scoring was well tolerated. The implications of this for future research and clinical practice are discussed. In 6 patients only 1 pain mechanism was identified (visceral 4, deep somatic 2). Two mechanisms were present in 8 patients and 3 mechanisms in 6 patients. The deep somatic mechanism was identified in 15 patients, visceral mechanism in 13, neurogenic in 10 and superficial somatic in 2. The most common combination of mechanisms was neurogenic/visceral/deep somatic (5 patients) and neurogenic/deep somatic (4 patients). No patient had neurogenic pain alone or superficial pain alone. To achieve optimal analgesia, a mean of 2.8 drug classes per patient was required (range: 1–5). All 20 patients required an opioid, and in 2 patients with visceral pain only, morphine was the initial and sole analgesic used. None of the 15 patients with deep somatic pain achieved acceptable pain relief with an anti-inflammatory drug alone at conventional dose levels. It is concluded that the approach is feasible, and prospective assessment and validation of the response of these proposed mechanism categories to specific drug classes is now underway. Assessment of the anti-inflammatory responsive component of nociceptive cancer pain has emerged as a priority for further investigation." @default.
• W2000856937 created "2016-06-24" @default.
• W2000856937 creator A5001122469 @default.
• W2000856937 creator A5006735328 @default.
• W2000856937 creator A5027037889 @default.
• W2000856937 creator A5046310520 @default.
• W2000856937 creator A5048587197 @default.
• W2000856937 creator A5073686488 @default.
• W2000856937 creator A5079630978 @default.
• W2000856937 creator A5086238426 @default.
• W2000856937 date "1992-11-01" @default.
• W2000856937 modified "2023-10-11" @default.
• W2000856937 title "Description of a mechanistic approach to pain management in advanced cancer. Preliminary report" @default.
• W2000856937 cites W1963668674 @default.
• W2000856937 cites W1965041095 @default.
• W2000856937 cites W1970892256 @default.
• W2000856937 cites W1980241193 @default.
• W2000856937 cites W1990487641 @default.
• W2000856937 cites W1999449112 @default.
• W2000856937 cites W2004035928 @default.
• W2000856937 cites W2010008400 @default.
• W2000856937 cites W2012076132 @default.
• W2000856937 cites W2022161953 @default.
• W2000856937 cites W2035259353 @default.
• W2000856937 cites W2038873054 @default.
• W2000856937 cites W2044974031 @default.
• W2000856937 cites W2062271329 @default.
• W2000856937 cites W2072790599 @default.
• W2000856937 cites W2089641069 @default.
• W2000856937 cites W2104144273 @default.
• W2000856937 cites W2162638249 @default.
• W2000856937 cites W2165908307 @default.
• W2000856937 cites W2317888114 @default.
• W2000856937 cites W2318080502 @default.
• W2000856937 cites W2411555101 @default.
• W2000856937 cites W2412061457 @default.
• W2000856937 cites W2418134951 @default.
• W2000856937 doi "https://doi.org/10.1016/0304-3959(92)90256-b" @default.
• W2000856937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1283009" @default.
• W2000856937 hasPublicationYear "1992" @default.
• W2000856937 type Work @default.
• W2000856937 sameAs 2000856937 @default.
• W2000856937 citedByCount "50" @default.
• W2000856937 countsByYear W20008569372012 @default.
• W2000856937 countsByYear W20008569372013 @default.
• W2000856937 countsByYear W20008569372014 @default.
• W2000856937 countsByYear W20008569372015 @default.
• W2000856937 countsByYear W20008569372018 @default.
• W2000856937 countsByYear W20008569372019 @default.
• W2000856937 countsByYear W20008569372023 @default.
• W2000856937 crossrefType "journal-article" @default.
• W2000856937 hasAuthorship W2000856937A5001122469 @default.
• W2000856937 hasAuthorship W2000856937A5006735328 @default.
• W2000856937 hasAuthorship W2000856937A5027037889 @default.
• W2000856937 hasAuthorship W2000856937A5046310520 @default.
• W2000856937 hasAuthorship W2000856937A5048587197 @default.
• W2000856937 hasAuthorship W2000856937A5073686488 @default.
• W2000856937 hasAuthorship W2000856937A5079630978 @default.
• W2000856937 hasAuthorship W2000856937A5086238426 @default.
• W2000856937 hasConcept C111472728 @default.
• W2000856937 hasConcept C121608353 @default.
• W2000856937 hasConcept C126322002 @default.
• W2000856937 hasConcept C138885662 @default.
• W2000856937 hasConcept C15490471 @default.
• W2000856937 hasConcept C170493617 @default.
• W2000856937 hasConcept C177713679 @default.
• W2000856937 hasConcept C1862650 @default.
• W2000856937 hasConcept C2778904085 @default.
• W2000856937 hasConcept C2779134260 @default.
• W2000856937 hasConcept C2779794527 @default.
• W2000856937 hasConcept C2780820201 @default.
• W2000856937 hasConcept C2781118164 @default.
• W2000856937 hasConcept C42219234 @default.
• W2000856937 hasConcept C71924100 @default.
• W2000856937 hasConcept C89611455 @default.
• W2000856937 hasConceptScore W2000856937C111472728 @default.
• W2000856937 hasConceptScore W2000856937C121608353 @default.
• W2000856937 hasConceptScore W2000856937C126322002 @default.
• W2000856937 hasConceptScore W2000856937C138885662 @default.
• W2000856937 hasConceptScore W2000856937C15490471 @default.
• W2000856937 hasConceptScore W2000856937C170493617 @default.
• W2000856937 hasConceptScore W2000856937C177713679 @default.
• W2000856937 hasConceptScore W2000856937C1862650 @default.
• W2000856937 hasConceptScore W2000856937C2778904085 @default.
• W2000856937 hasConceptScore W2000856937C2779134260 @default.
• W2000856937 hasConceptScore W2000856937C2779794527 @default.
• W2000856937 hasConceptScore W2000856937C2780820201 @default.
• W2000856937 hasConceptScore W2000856937C2781118164 @default.
• W2000856937 hasConceptScore W2000856937C42219234 @default.
• W2000856937 hasConceptScore W2000856937C71924100 @default.
• W2000856937 hasConceptScore W2000856937C89611455 @default.
• W2000856937 hasIssue "2" @default.
• W2000856937 hasLocation W20008569371 @default.
• W2000856937 hasOpenAccess W2000856937 @default.
• W2000856937 hasPrimaryLocation W20008569371 @default.
• W2000856937 hasRelatedWork W1985040177 @default.
• W2000856937 hasRelatedWork W2118258705 @default.
• W2000856937 hasRelatedWork W2128130849 @default.

• next